Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Maria Dam Kosmetisk Klinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 7.5% 7.5%   Bankruptcy risk   2.6% 3.9% 2.2% 8.4% 7.0% 2.4% 16.2% 16.2%   Credit score (0-100)   63 51 66 28 34 62 11 11   Credit rating   BBB BBB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,158 1,231 1,795 1,745 2,100 2,654 0.0 0.0   EBITDA   412 211 492 -490 127 812 0.0 0.0   EBIT   345 87.6 328 -698 -6.1 673 0.0 0.0   Pre-tax profit (PTP)   329.4 85.8 315.6 -735.5 -42.4 620.9 0.0 0.0   Net earnings   244.3 65.3 243.2 -576.4 -35.7 479.8 0.0 0.0   Pre-tax profit without non-rec. items   329 85.8 316 -735 -42.4 621 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   366 577 518 1,106 1,017 879 0.0 0.0   Shareholders equity total   375 290 533 -243 -279 201 141 141   Interest-bearing liabilities   175 167 0.0 1,709 1,500 1,429 0.0 0.0   Balance sheet total (assets)   1,131 895 1,349 2,001 2,024 2,124 141 141   Net Debt   -332 -66.6 -537 1,269 990 556 -141 -141     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,158 1,231 1,795 1,745 2,100 2,654 0.0 0.0   Gross profit growth   -4.2% 6.4% 45.7% -2.8% 20.4% 26.4% -100.0% 0.0%   Employees   1 1 1 3 3 3 0 0   Employee growth %   0.0% 0.0% 0.0% 200.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,131 895 1,349 2,001 2,024 2,124 141 141   Balance sheet change%   26.9% -20.9% 50.8% 48.3% 1.1% 4.9% -93.4% 0.0%   Added value   412.5 211.5 491.8 -490.3 201.5 811.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   137 87 -222 380 -222 -277 -879 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 -2.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   29.8% 7.1% 18.3% -40.0% -0.3% 25.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   34.4% 9.0% 29.3% -38.8% -0.3% 30.6% 0.0% 0.0%   ROI %   76.7% 17.2% 63.7% -61.6% -0.4% 43.1% 0.0% 0.0%   ROE %   69.2% 19.6% 59.0% -45.5% -1.8% 43.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   33.4% 34.4% 40.7% -10.9% -12.4% 9.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -80.5% -31.5% -109.1% -258.8% 777.0% 68.5% 0.0% 0.0%   Gearing %   46.6% 57.6% 0.0% -703.5% -538.1% 710.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   21.0% 2.9% 15.4% 4.4% 2.3% 3.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.6 0.9 0.3 0.3 0.5 0.0 0.0   Current Ratio   1.0 0.5 0.8 0.3 0.4 0.6 0.0 0.0   Cash and cash equivalent   506.8 233.8 536.6 440.3 510.0 873.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   35.4 -267.2 -143.5 -1,468.5 -1,415.8 -782.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   412 211 492 -163 67 271 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   412 211 492 -163 42 271 0 0   EBIT / employee   345 88 328 -233 -2 224 0 0   Net earnings / employee   244 65 243 -192 -12 160 0 0